BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CARS, P49589, 833, ENSG00000110619 AND Staging
12 results:

  • 1. lung cancer survival prediction and biomarker identification with an ensemble machine learning analysis of tumor core biopsy metabolomic data.
    Miller HA; van Berkel VH; Frieboes HB
    Metabolomics; 2022 Jul; 18(8):57. PubMed ID: 35857204
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Effect of treatments for head and neck cancer on sinus shadow on computed tomography.
    Hemmi T; Suzuki J; Ishii R; Ikeda R; Kobayashi Y; Ikushima H; Nomura K; Sugawara M; Ohkoshi A; Katori Y
    Auris Nasus Larynx; 2022 Dec; 49(6):1019-1026. PubMed ID: 35341622
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Extraskeletal myxoid chondrosarcoma: A high incidence of metastatic disease to lymph nodes.
    Claxton MR; Reynolds G; Wenger DE; Rose PS; Houdek MT
    J Surg Oncol; 2020 Dec; 122(8):1662-1667. PubMed ID: 32808356
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Improving Timeliness of lung cancer Diagnosis and staging Investigations Through Implementation of Standardized Triage Pathways.
    Mullin MLL; Tran A; Golemiec B; Stone CJL; Noseworthy C; O'Callaghan N; Parker CM; Digby GC
    JCO Oncol Pract; 2020 Oct; 16(10):e1202-e1208. PubMed ID: 32639927
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Correlation between maximal tumor diameter of fresh pathology specimens and computed tomography images in lung adenocarcinoma.
    Park CH; Kim TH; Lee S; Moon DH; Park HS
    PLoS One; 2019; 14(1):e0211141. PubMed ID: 30682110
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Adjuvant Systemic Therapy in Patients With Early-Stage NSCLC Treated With Stereotactic Body Radiation Therapy.
    Ernani V; Appiah AK; Marr A; Zhang C; Zhen W; Smith LM; Ganti AK
    J Thorac Oncol; 2019 Mar; 14(3):475-481. PubMed ID: 30503890
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer.
    Ercelep O; Alan O; Sahin D; Telli TA; Salva H; Tuylu TB; Babacan NA; Kaya S; Dane F; Ones T; Alkis H; Adli M; Yumuk F
    Clin Transl Oncol; 2019 Apr; 21(4):499-504. PubMed ID: 30229391
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and long-term prognostic analysis.
    Xu LL; Yang Y; Wang Z; Wang XJ; Tong ZH; Shi HZ
    BMC Pulm Med; 2018 Apr; 18(1):56. PubMed ID: 29615010
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. External Validation of a Survival Nomogram for Non-Small Cell lung cancer Using the National cancer Database.
    Young KA; Efiong E; Dove JT; Blansfield JA; Hunsinger MA; Wild JL; Shabahang MM; Facktor MA
    Ann Surg Oncol; 2017 Jun; 24(6):1459-1464. PubMed ID: 28168388
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Analysis on the Prognostic and Survival Factors of Synchronous Multiple Primary lung cancer].
    Guo H; Mao F; Zhang H; Qiu Y; Shen-Tu Y
    Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):21-27. PubMed ID: 28103969
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ALDH1 Expression and the Prognosis of lung cancer: A Systematic Review and Meta-Analysis.
    Wei D; Peng JJ; Gao H; Zhang T; Tan Y; Hu YH
    Heart Lung Circ; 2015 Aug; 24(8):780-8. PubMed ID: 25921687
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Accuracy of recorded tumor, node, and metastasis stage in a comprehensive cancer center.
    Brierley JD; Catton PA; O'Sullivan B; Dancey JE; Dowling AJ; Irish JC; McGowan TS; Sturgeon JF; Swallow CJ; Rodrigues GB; Panzarella T
    J Clin Oncol; 2002 Jan; 20(2):413-9. PubMed ID: 11786568
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.